We would like to provide an update regarding the ongoing uncertainty surrounding federal vaccine recommendations and explain how these developments may affect annual Influenza, COVID-19 and additional vaccine standing orders, protocols, and pharmacist vaccination authority in your state.
As many of you are aware, significant changes occurred within the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) beginning in June 2025. Subsequent actions included modifications to certain federal vaccine recommendations and immunization schedules. However, in March 2026, a federal district court issued a preliminary injunction that effectively stayed the implementation of many vaccine recommendation changes made after June 11, 2025, while litigation continues. As a result, federal vaccine guidance remains in a state of legal and regulatory uncertainty, and many stakeholders have interpreted the ruling as reinstating the vaccine recommendations and immunization schedules that were in effect prior to those actions.
Because the litigation remains ongoing and appeals are expected, the legal status of certain vaccine recommendations continues to evolve. Consequently, R.J. Hedges & Associates is exercising caution before making broad revisions to annual Influenza, COVID-19 and additional vaccine standing orders, protocols, or vaccination guidance documents.
It is important to understand that a pharmacist's authority to administer vaccines is not determined solely by CDC or ACIP recommendations. Rather, pharmacist vaccination authority is governed primarily by state law, state regulations, and guidance issued by each state's Board of Pharmacy and, in some cases, Board of Medicine or Department of Health. Many state laws specifically reference ACIP recommendations, CDC immunization schedules, standing orders, physician protocols, collaborative practice agreements, or other federal guidance. Because these laws vary significantly from state to state, the impact of the current federal uncertainty will differ depending on your jurisdiction.
For example, some states grant pharmacists independent authority to administer vaccines that are recommended by ACIP or included on the CDC immunization schedule. Other states require prescriptions, standing orders, physician protocols, collaborative practice agreements, or limit administration based on patient age, vaccine type, or specific statutory language. As federal recommendations change, are challenged, or are temporarily stayed by court action, questions may arise regarding which recommendations remain legally recognized for purposes of pharmacist authority and payer coverage.
An additional consideration involves the federal Public Readiness and Emergency Preparedness (PREP) Act. During the COVID-19 Public Health Emergency, the PREP Act provided pharmacists, pharmacy interns, and pharmacy technicians with certain federal authorities and liability protections that, in many cases, preempted more restrictive state laws and allowed vaccine administration that might not otherwise have been authorized under state pharmacy practice acts. However, PREP Act authorities are generally tied to federal declarations, ACIP and CDC recommendations that define the scope of covered countermeasures and authorized activities. As a result, the current uncertainty surrounding CDC and ACIP recommendations has generated questions regarding the extent to which PREP Act-based authorities may continue to apply when underlying federal vaccine recommendations are modified, challenged, or subject to ongoing litigation. While the PREP Act has been extended through December 31, 2029, pharmacies should be cautious about assuming that federal authority automatically overrides state law in the current environment.
Potential legal and compliance considerations include:
Given these complexities, we strongly recommend that pharmacies:
At this time, R.J. Hedges & Associates will continue monitoring federal litigation, CDC updates, ACIP activities, state regulatory developments, and Board of Pharmacy guidance. As greater regulatory clarity emerges, we will evaluate whether updates to our Influenza, COVID-19 and additional vaccine standing orders and protocol templates are warranted.
Until then, pharmacies should not assume that guidance applicable in one state applies universally. The most reliable source for determining current pharmacist vaccination authority remains your state's statutes, regulations, and official guidance from your State Board of Pharmacy.
We encourage all clients to proactively contact their State Board of Pharmacy if there is any uncertainty regarding vaccine administration authority, protocol requirements, age limitations, or the applicability of current CDC and ACIP recommendations within their jurisdiction.
As always, we will continue to monitor developments and provide updates as additional information becomes available.
References
Disclaimer: This communication is intended for educational and compliance awareness purposes only and does not constitute legal advice. Pharmacies should consult qualified legal counsel and applicable state regulatory authorities regarding state-specific requirements.
Ready to strengthen your pharmacy's compliance foundation? Contact R.J. Hedges & Associates to learn more about our pharmacy compliance programs and how we can help support your operation.